Evaluating Engineered CD4 and CD8 T Cells in the Treatment of Advanced PDA 2025 Partnership with the Alliance for Cancer Gene Therapy Philip Greenberg, MD, Fred Hutchinson Cancer Research Center Read More
EGFR-Positive Lung Cancer: Treatment-Induced Mutagenesis, Exon-20, and Strategies to Delay Relapses 2025 Partnership with the Israel Cancer Research Fund Yosef Yarden, PhD, Weizmann Institute of Science Read More
KDM3B as a Genotype-Specific Target in IDH1/2-Mutant Clonal Hematopoiesis and Leukemia 2025 Momentum Fellow Hannah Fay, PhD, Memorial Sloan Kettering Cancer Center Read More
Investigating the Mechanisms Through Which Gliomas Integrate into Neuronal Circuitries 2025 Momentum Fellow Alessandro Matera, PhD, University of Lausanne Read More
Integrating Multiomics Data to Characterize Lung Cancer and Tumor Microenvironment 2025 Momentum Fellow Oriol Pich, MD, PhD, The Francis Crick Institute Read More
Precision Therapy for Treating Li-Fraumeni Syndrome: Can Rezatapopt Delay or Prevent Tumorigenesis in Mice with a Germline TP53-Y220C Mutation? 2025 ASPIRE Award Gerard Zambetti, PhD, St. Jude Children's Research Hospital Read More
